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Objective: Prosima (Ethicon, Somerville, NJ, USA) is a novel procedure for treating pelvic organ prolapse
(POP) that uses nonanchored vaginal mesh. However, nonﬁxation of the mesh may limit effectiveness.
The aim of this study was to evaluate the safety, efﬁcacy, and limitations of this procedure.
Materials and methods: From January 2011 through to December 2011, 52 patients with symptomatic
POP  Stage 2 undergoing the Prosima procedure at a tertiary hospital were enrolled consecutively in
this prospective study. A Data and Safety Monitoring Plan (DSMP) was developed to assess the results.
Results: Fifty of the 52 patients (96%) attended the 3e6-month postoperative assessment. Symptom and
quality-of-life scores were found to have improved signiﬁcantly after surgery (p < 0.05). Forty-two pa-
tients (84%) underwent successful treatment for POP (Stage 0-1). The other eight patients (16%) were
found to have recurrent Stage 2 anterior vaginal wall prolapse, although most of them (5/8) were
asymptomatic. The highest morbidity, namely vaginal mesh exposure, occurred in four patients (8%) and
was managed as a minor issue. Statistical analysis showed that anatomic recurrence was signiﬁcantly
(p < 0.05) associated with a “preoperative Ba  þ4 cm” (odds ratio ¼ 20.57), “conservation of the
prolapsed uterus” (odds ratio ¼ 10.56) and “use of a concomitant midurethral sling” (odds ratio ¼ 0.076).
Conclusion: Prosima seems to have limitations when used to manage severe anterior vaginal wall pro-
lapse and concomitant surgery may further affect its effectiveness. The information obtained from this
study's DSMP will contribute to developing a strategy to improve the use of nonanchored vaginal mesh
for POP repair.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Based on the most recent survey, the lifetime risk of undergoing
surgery for pelvic organ prolapse (POP) is 19% among the general
female population, which is higher than the previously reported
rate of 11e12% [1]. However, attempts to correct this problem still
result in a high failure rate and a signiﬁcant number of patients
require a second surgical procedure [2]. Most patients (60%) whos and Gynecology, Taichung
chung Harbor Road, Taichung
).
rk.
bstetrics & Gynecology. Publishedundergo POP repair are aged < 60 years [3]. Therefore, an ideal
surgical intervention for POP should be one that is safe, efﬁcacious,
and durable.
Recently, in an attempt to improve surgical outcomes, synthetic
mesh has been increasingly used during POP reconstructive pelvic
surgery. An updated Cochrane review showed that a native tissue
anterior vaginal repair is associated with more failures than when
polypropylene mesh is used as an overlay (relative risk ¼ 2.14) or
when armed transobturator mesh is used (relative risk ¼ 3.55) [4].
In recent years, various trocar-guided vaginal mesh kits have been
widely used for POP repair. High anatomic success rates and
satisfactory functional outcomes have been reported over a number
of large case series [5e7], various randomized controlled trials
[8,9], and various prospective comparison studies using a variety ofby Elsevier Taiwan LLC. All rights reserved.
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correction is sustained during both short-term [5,8e10] and
medium-term [6,7] follow-up.
Recently, a trocar-free POP repair system using nonanchored
mesh and a vaginal support device (VSD; Prosima, Ethicon, Som-
erville, NJ, USA) has been developed and is thought to provide true
tension-free support with less vaginal distortion and reduced band
formation [11,12]; however, nonﬁxation of the mesh may result in a
suboptimal suspension effect with this procedure. According to
recent results reported in the literature, the objective success rates
for POP repair (Stage 0e1) using the Prosima procedure are only
76.9% and 69.1% at 1- and 2-year follow-up, respectively. These
rates are obviously inferior to those achieved by trocar-guided
vaginal mesh kits (from >80% to >90%) over the same or even
longer follow-up periods [5e10].
In order to further understand the safety, efﬁcacy, and possible
limitations of the nonanchored vaginal mesh procedure (Prosima),
we developed a Data and Safety Monitoring Plan (DSMP) to study
the surgical results at the 3e6-month follow-up in this prospective
clinical trial. The DSMP is a system for appropriate oversight and
monitoring of the conduct of a clinical investigation. This oversight
ensures the safety of theparticipants and the validity and integrity of
the data. A DSMP should be commensuratewith the risks associated
with the investigation and can be as simple as the investigators
annually submitting their safety andAdverse event (AE) information
to the Institutional Review Board [13]. Statistical analysis was per-
formed to evaluate the factors that may affect the POP treatment
outcome when the Prosima procedure is used. The information
obtained should contribute to the formation of a strategy for the use
of nonanchored vaginal mesh as a means of POP repair.
Materials and methods
Patients
Patients were included based on the inclusion and exclusion
criteria described by the Prosima study investigators involved in
previous multicenter studies [11,12]. In brief, women presenting
with symptomatic POP  Stage 2 and scheduled for augmented
reconstructive pelvic surgery at a tertiary hospital were enrolled
consecutively in this prospective follow-up study. The exclusion
criteria included previous prolapse mesh repair, hysterectomy
within 6 months of the index surgery, diseases known to affect
bladder or bowel function, and an inability to complete the study.
All patients gave informed consent for both the surgery and the
study after a full explanation. Approval for this prospective clinical
trial was obtained from the Ethics Committee at our institution (IRB
Taichung Veterans General Hospital, TCVGH No. CE11280). A DSMP
investigation was conducted targeting the patients who had
enrolled during the 1st year of this study from January 2011 through
to December 2011.
Study protocol
Prior to the surgery, each patient underwent an interview that
included a standard symptom and quality-of-life questionnaire
[Urogenital Distress Inventory-6 (UDI-6) and Pelvic Organ Prolapse
Impact Questionnaire-7 (POPIQ-7)], a pelvic examination, a cough
stress test with a comfortably full bladder, and a multichannel
urodynamic study. The formation and validation of the question-
naire that we use in our daily practice and as a research instrument
have been detailed previously [14]. The pelvic examination was
performed with the patients in a 45 upright position in an exam-
ining chairwhile performing theValsalvamaneuverwithmaximum
effort. POP was quantiﬁed according to the Pelvic Organ ProlapseQuantitation (POPQ) system [15]. The multichannel urodynamic
study was performed according to methods, deﬁnitions, and units
that conform to the standards proposed by the International Uro-
gynecological Association and the International Continence Society
[16]. The leak point pressure and the urethral pressure proﬁle were
both determined with the prolapse protruding and with the pro-
lapse reduced using a vaginal pessary. Patients were identiﬁed as
having “occult” type urodynamic stress incontinence (USI) if stress-
induced urine loss was demonstrated in the absence of a detrusor
contraction with the prolapse reduced but not with the prolapse
protruding [16]. Follow-up examinations were performed post-
operatively at 6 weeks, 3 months, 6 months, and then annually in
order to assess the anatomic and functional outcomes of the treat-
ment. A follow-up urodynamic study was not routinely performed
but was done if urinary symptoms or a positive cough stress test
were indicated the need. The efﬁcacy of the surgery was considered
to be “successful” when patients were free of pressure or bulge
symptoms and when the vaginal support was POPQ Stage 0e1. A
“failed” surgical result was deﬁned as a prolapse with a POPQ Stage
 2, even without associated pressure or bulge symptoms.
Surgical procedures
The principal surgeon (M.J.H.) was proﬁcient in vaginal recon-
structive surgery with and without mesh. Before this study was
conducted, live surgeries by a key member of the Prosima study
investigators (M.P.C.) were observed by M.J.H. and the manufac-
turer's instructions for use of the kit were reviewed. The combined
(anterior and posterior) Prosima procedure was performed on all
patients. Concomitant surgery for the treatment of a prolapsed
uterus, including vaginal hysterectomy with McCall culdoplasty or
uterine conservation with McCall culdoplasty and partial trache-
lectomy, were carried out if necessary [14]. For the management of
concurrent USI, either overt or occult type, a midurethral sling
(TVT-O, Ethicon) was used. Postoperatively, all patients underwent
transurethral bladder drainage. A voiding trial began on post-
operative Day 3. A patient's catheter was removed once the patient
could void freely and the postvoid residual was < 25% of the total
bladder volume on two occasions. The VSD was removed from
patients at postoperative Day 25 based on animal studies that have
demonstrated that the maximum pullout force of mesh is achieved
25 days after implantation [17].
Statistical analysis
A statistical power calculationwas not done because all patients
who underwent the Prosima procedure in our institution were
asked to register as part of this prospective follow-up study. Clinical
data are presented as mean ± standard deviation, median (range),
or percentage as appropriate. Univariate analysis was used to
compare the pre- and postoperative POPQ stages for all three
vaginal compartments and the proportion of pelvic symptoms that
were present prior to and after surgery. Fifteen important clinical
parameters, namely operation sequence, baseline Ba, C, and Bp
(anterior, apical, and posterior) values, POPQ stages, age, parity,
body mass index, diabetes mellitus, chronic constipation, occupa-
tional/recreational heavy lifting, prior prolapse surgery, concomi-
tant midurethral sling, conservation of the prolapsed uterus, and
vaginal mesh exposure, were also compared between the outcome
groups by univariate analysis. Additional multivariate logistic
regression analysis was conducted to evaluate the association of
these clinical variables with surgical outcomes. A p value < 0.05was
considered to be statistically signiﬁcant. All analyses were per-
formed with statistical software SAS version 9.1.3 (SAS Institute Inc,
Cary, NC, USA).
Table 1
Preoperative characteristics of the patients who underwent reconstructive pelvic
surgery using a nonanchored vaginal mesh procedure (n ¼ 50).
Patient characteristics Value Range
Mean age (y) 60.5 ± 9.3 (38e78)
Median parity (no.) 3 (1e6)
Mean body mass index (kg/m2) 24.9 ± 2.9 (20.0e31.1)
Menopause 88 (44/50)
Prior prolapse repair 8 (4/50)
Prior hysterectomy 18 (9/50)
Urodynamic stress incontinence 38 (19/50)
Diabetes mellitus 18 (9/50)
Chronic constipation 22 (11/50)
Professional/recreational heavy lifting 22 (11/50)
Data are presented as % unless otherwise indicated.
Table 3
Anatomic outcome assessed by Pelvic Organ Prolapse Quantitation system in pa-
tients who underwent reconstructive pelvic surgery using a nonanchored vaginal
mesh procedure at follow-up intervals of 3e6 months (n ¼ 50).
POPQ Baseline Follow-up p
Anterior (Ba) site <0.001a
Stage 0 0 (0) 40 (80)
Stage I 1 (2) 2 (4)
Stage II 17 (34) 8 (16)
Stage III 32 (64) 0 (0)
Stage IV 0 (0) 0 (0)
Apical (C) site <0.001a
Stage 0 1 (2) 42 (84)
Stage I 11 (22) 8 (16)
Stage II 19 (38) 0 (0)
Stage III 15 (30) 0 (0)
Stage IV 4 (8) 0 (0)
Posterior (Bp) site <0.001a
Stage 0 2 (4) 48 (96)
Stage I 9 (18) 2 (4)
Stage II 32 (64) 0 (0)
Stage III 7 (14) 0 (0)
Stage IV 0 (0) 0 (0)
Data are presented as n (%).
POPQ ¼ Pelvic Organ Prolapse Quantitation.
a Wilcoxon signed-rank test.
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Patient characteristics
Of the ﬁrst 52 patients who were enrolled consecutively into
this prospective clinical trial, 50 (96%) completed the 3e6-month
follow-up evaluation and were assessed accordingly by the DSMP.
Patient characteristics are shown in Table 1. Nine of the 50 patients
(18%) had undergone a hysterectomy prior to this operation for a
variety of reasons. Only 8% (4 of 50) had undergone prior prolapse
surgery, which means that most of the patients enrolled in this
study were primary POP patients. According to the preoperative
urodynamic study results, therewere 19 patients (38%) with USI (13
overt and 6 occult type, respectively).
Surgical results
The surgical information had a mean follow-up interval of
4.7 ± 1.3 (range 3e6) months and is summarized in Table 2. A total
of eight patients (16%) had recurrent POP Stage 2 in the anterior
compartment. Among these eight, ﬁve remained asymptomatic and
three had vaginal bulging. Therefore, the objective and subjective
success rates of surgery were 84% (42/50) and 94% (47/50),
respectively. Concomitant USI was cured in 17 patients (89.5%) by
the use of an additional midurethral sling. Of the 20 patients who
chose to preserve their uterus, partial trachelectomy was necessary
in six (30%). The complication rates were low. The highest rate was
8% for the four patients having anterior vaginal wall mesh expo-
sure, which was successfully treated in all patients. One patient,Table 2
Surgical results of the patients who underwent reconstructive pelvic surgery using a
nonanchored vaginal mesh procedure at follow-up intervals of 3e6months (n¼ 50).
Parameters Value Range
Basic clinical data
Mean hospital stay (d) 5.3 ± 1.1 (4e9)
Mean Foley drainage (d) 3.4 ± 1.1 (3e8)
Mean total operation time (min) 134 ± 25.7 (90e190)
Mean estimated blood loss (mL) 100 ± 150.6 (50e800)
Concomitant procedures for prolapsed uterus
VTH with McCall culdoplasty 51.2 (21/41)
McCall culdoplasty with/without trachelectomy 48.8 (20/41)
Treatment outcome of POP
Success (Stage 0e1) 84 (42/50)
Failure (Stage 2) 16 (8/50)
Surgical complications
Retropubic hematoma 2 (1/50)
De novo stress urinary incontinence 5.4 (2/37)
De novo urgency urinary incontinence 4.7 (2/43)
Vaginal mesh exposure 8 (4/50)
Data are presented as % or mean ± SD, unless otherwise indicated.
POP ¼ pelvic organ prolapse; USI ¼ urodynamic stress incontinence; VTH ¼ vaginal
total hysterectomy.who also had a recurrent symptomatic anterior vaginal prolapse,
underwent partial removal of the mesh and anterior colporrhaphy
in the operating room. The other three patients underwent partial
mesh excision and were treated with topical estrogen cream at the
outpatient clinic.
The anatomic outcomes, as assessed by comparing the preop-
erative and postoperative POPQ stages, are shown in Table 3. The
Wilcoxon signed-rank test was used to assess the difference be-
tween repeated measurements of the POPQ stages prior to and
after surgery. The results indicated that, at follow-up, there was a
statistically signiﬁcant (p < 0.001) improvement in all POPQ mea-
surements across the three vaginal compartments.
The functional outcomes, assessed by comparing the occurrence
of pre- and postoperative pelvic symptoms and their effect on
quality of life, are shown in Table 4. Statistically signiﬁcant im-
provements from baselinewere observed in the UDI-6 and POPIQ-7
scores as well as in most pelvic symptoms except for defecatory
difﬁculty and dyspareunia.Table 4
Functional outcomes assessed by standard symptoms and a quality of life ques-
tionnaire in patients who underwent reconstructive pelvic surgery using a non-






Vaginal bulging 100 (50/50) 6 (3/50) <0.001a
Pelvic pressure 24 (12/50) 2 (1/50) 0.001*
Urinary urgency 54 (27/50) 16 (8/50) <0.001a
Stress urine
incontinence
26 (13/50) 8 (4/50) 0.007a
Voiding difﬁculty 42 (21/50) 4 (2/50) <0.001*
Defecatory
difﬁculty
28 (14/50) 22 (11/50) 0.549a
Dyspareuniab 36.4 (8/22) 26.7 (4/15) 0.500a
UDI-6 5.69 ± 3.23 (0~14) 1.96 ± 1.99 (0~11) <0.001c
POPIQ-7 5.92 ± 4.51 (0~19) 1.48 ± 3.03 (0~17) <0.001c
Data are presented as % or mean ± SD, unless otherwise indicated.
POPIQ ¼ Pelvic Organ Prolapse Impact Questionnaire; UDI ¼ urogenital distress
inventory.
a McNemar test.
b The symptom “dyspareunia” was evaluated in 22 sexually active patients prior
to surgery and in 15 sexually active patients after surgery.
c Wilcoxon test.
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Table 5 shows the results when a comparison of 15 important
clinical variables across the outcome groups was carried out by
univariate analysis. In addition, a multivariate logistical regression
analysis was also carried out and this showed that a failed surgical
outcome (recurrent POPQ stage 2) had a strong associationwith a
preoperative Ba of  þ4 cm (p ¼ 0.039, odds ratio ¼ 20.57), with
conservation of a prolapsed uterus (p ¼ 0.045, odds ratio ¼ 10.56),
and with the concomitant introduction of a midurethral sling
(p ¼ 0.039, odds ratio ¼ 0.076). The value of the estimated odds
ratios implies that a severe anterior vaginal prolapse (i.e., 4 cm
beyond the hymen) and conservation of a prolapsed uterus during
the surgery predisposes patients to surgical failure using the non-
anchored vaginal mesh procedure (Prosima). By contrast, a
concomitantly performed midurethral sling procedure seemed to
augment the suspension effect of the procedure.
Discussion
We developed a DSMP for this prospective clinical trial and
found that the efﬁcacy and safety of the nonanchored vaginal mesh
procedure (Prosima) for treatment of POP was promising when
assessed at short-term follow-up. However, eight cases (16%)
showed an early anatomic recurrence (POPQ Stage 2) in the anterior
vaginal compartment, although most of them (5/8) remained
asymptomatic. After a statistical analysis, we found that recurrence
was strongly (p < 0.05) associated with “preoperative severe
anterior vaginal wall prolapse” at a cutoff Ba value of  þ4 cm.
Meanwhile, two concomitant surgeries, namely “conservation of a
prolapsed uterus” and the introduction of a “midurethral sling”
were related to a negative or positive outcome, respectively,
probably because of the suspension effect of each procedure.
A homogeneous patient population was enrolled in this study.
Most cases (92%) were with primary POP and all of these patients
underwent the combined (anterior and posterior) Prosima proce-
dure with a VSD in place for 25 days. This internal consistency hasTable 5
Comparison of 15 important clinical variables between outcome groups after
reconstructive pelvic surgery using a nonanchored vaginal mesh procedure at
follow-up intervals of 3e6 months (n ¼ 50).
Variables Successful (n ¼ 42) Failed (n ¼ 8) p
Median operation
sequence
23 (2~52) 24 (1~51) 0.711a
Mean baseline Ba
point (cm)
2.5 ± 2.0 (2~þ6.5) 3.9 ± 1.9 (þ1~þ6.5) 0.056a
Mean baseline C
point (cm)
0.9 ± 3.0 (4~þ8) 0.3 ± 3.3 (6~þ4) 0.537a
Mean baseline Bp
point (cm)
0.1 ± 1.9 (3~þ4.5) 0.6 ± 0.9 (2~þ1) 0.553a
Median baseline
POPQ stage
3 (2~4) 3 (2~3) 0.986a
Mean BMI (kg/m2) 25 ± 3.0 (20.0~31.1) 24.7 ± 2.0 (21.5~27.3) 0.874a
Mean age (y) 60.9 ± 9.8 (43~78) 58.9 ± 6.5 (48~67) 0.499a
Median parity (no.) 3 (1~6) 3 (1~4) 0.870a
Diabetes mellitus 19.1 (8/42) 12.5 (1/8) 1.000b
Chronic constipation 23.8 (10/42) 12.5 (1/8) 0.666b
Heavy lifting 26.2 (11/42) 0 (0/8) 0.174b
Prior prolapse
surgery
7.1 (3/42) 12.5 (1/8) 0.514b
Midurethal sling 42.9 (18/42) 12.5 (1/8) 0.134b
Uterine conservation 41.7 (15/36) 100 (5/5) 0.002b
Vaginal mesh
exposure
4.8 (2/42) 25 (2/8) 0.115b
Data are presented as % or mean ± SD, unless otherwise indicated.
POPQ ¼ Pelvic Organ Prolapse Quantiﬁcation.
a ManneWhitney test.
b Fisher exact test.the advantage of avoiding various confounding factors that might
affect the subsequent analysis of associations with surgical
outcome. By contrast, patients enrolled in previous multicenter
studies conducted by the Prosima study investigators underwent a
variety of different Prosima procedures (anterior, posterior, or
combined) and had the VSD in place for a varying number of days.
In these studies, because of the variations in procedure, it was
found that having a VSD in place <21 days was signiﬁcantly asso-
ciated with surgical failure [11,12]. Despite the difference in study
designs, the demographic data for this study and the earlier studies,
including patient age, parity, menopausal status, and body mass
index, are similar. Therefore, the higher objective success rate of
84% (POPQ Stage 0e1) in our study compared to 76.9% in the pre-
vious multicenter studies may be caused by either the shorter
follow-up interval (4.7 months vs. 1 year) and/or the uniformly
longer VSD placement of 25 days.
However, the promising anatomic success rate (84%) in this
study is still inferior to the rates found for trocar-guided vaginal
mesh kits that are followed up for 3 months (95.3%) [5] and those
involving even longer follow-up intervals (90%) [6,7,9,10]. The
lower rate with the Prosima procedure is related to a subgroup of
patients who showed an early anatomic recurrence in the anterior
vaginal compartment. This recurrence, after statistical analysis, was
found to be strongly associated with a preoperative severe anterior
vaginal wall prolapse at a cutoff Ba value of  þ4 cm. Similar
ﬁndings have been reported in other studies that have analyzed the
risk factors associated with POP recurrence after surgery. These
studies have indicated that the anterior compartment is the most
vulnerable site and patients withmore advanced prolapse are more
likely to experience surgical failure [18,19]. However, this phe-
nomenon is not noted when POP repair is carried by trocar-guided
vaginal mesh kits, which are effective in all three vaginal com-
partments [5e10]. The aforementioned results suggest that the
different vaginal mesh kits each have their own unique design
points and these may therefore translate into special indications
and limitations with respect to POP repair.
The statistical analysis in this study also demonstrated that two
concomitant surgeries, namely “conservation of a prolapsed
uterus” and the “use of a midurethral sling”, had further negative or
positive outcome effects, respectively, on the suspension effect of
the Prosima procedure. These two procedures involve sites next to
the anterior vaginal segment (bladder base), so it is understandable
that they would affect any anterior vaginal wall repair. By analyzing
POPQ data, Rooney et al [20] found that the vaginal apex (C point)
showed a signiﬁcant correlation with both the anterior (Ba point)
and the posterior (Bp point) vaginal wall. However, the strength of
the correlation was higher between the C point and the Ba point
[20]. Another study conducted by Summers et al [21], who used
dynamic magnetic resonance scanning to determine the degree of
displacement of the anterior, apical, and urethral segments during
maximal straining, found that movement of the bladder base was
highly correlated with movement of the urethra (r ¼ 0.82) and
movement of the uterus (r¼ 0.73). Accordingly, conservation of the
prolapsed uterus during the Prosima procedure may place an
additional burden on the anterior mesh and thus have a negative
effect on anterior vaginal wall suspension. By contrast, a concom-
itant midurethral sling procedure ought to provide a further pro-
tective effect on the anterior repair by adding additional support to
the distal segment of the anterior vaginal wall. In fact, Goldberg
et al [22] found that suburethral sling procedures appeared to
signiﬁcantly reduce the risk of recurrent anterior vaginal wall
prolapse after reconstructive pelvic surgery.
In contrast to the early recurrence of the anterior vaginal repair
after the Prosima procedure, the optimal effects of apical and
posterior vaginal repairs are known to be associated with the
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differences in the severity of the prolapse, which may result in
different recurrence rates between anterior and posterior vaginal
wall repairs. In our patients, 64% had a  Stage 3 anterior vaginal
wall prolapse, but only 14% had a  Stage 3 posterior vaginal wall
prolapse. Another possible confounding factor is the presence of
additional McCall culdoplasty and partial trachelectomy, which are
prolapse repair procedures; these have been noted to affect
recurrence rates after POP repair [23]. Both the aforementioned
factors may distort the outcome of the Prosima procedure when
performed concomitantly.
Our results showed that USI is able to be successfully treated by
a concomitant midurethral sling and the Prosima procedure. The
89.5% cure rate was compatible with rates for a single procedure.
However, the 5% rate of de novo stress incontinence was lower than
that in studies by Altman et al (12%) [8] andWithagen et al (10%) [9]
after trocar-guided vaginal mesh operations. Low rates of 4e5%
were also noted in the multicenter studies conducted by the Pro-
sima study investigators [11,12]. A prospective and randomized
multicenter trial showed that de novo stress incontinence was
signiﬁcantly more common after trocar-guided vaginal mesh sur-
gery than after colporraphy. In comparison to baseline urody-
namics, vaginal mesh surgery seems to result in a signiﬁcant
decrease in maximal urethral closure pressures, whereas conven-
tional anterior colporraphy seems to have no signiﬁcant effect on
urodynamic parameters [24]. The nonanchored vaginal mesh pro-
cedure (Prosima), which requires less vaginal dissection together
with the concomitant midurethral sling operation, may explain the
low rate of de novo stress incontinence [11,12]. Although meta-
analysis has revealed that concurrent continence surgery at the
time of POP surgery does not signiﬁcantly reduce the rate of
postoperative stress incontinence [4], we suggest there should be
special consideration given to vaginal mesh operations because of
the high de novo rate. Moreover, if midurethral sling placement is
indicated, it should be encouraged when the nonanchored vaginal
mesh procedure is used because of its additional protective effect
with respect to prolapse repair. Further urodynamic studies are
needed to truly evaluate the effect of the nonanchored vaginal
mesh procedure on lower urinary tract functioning.
The advantages of the Prosima procedure found in this study
included a high subjective success rate, functional and quality-of-
life improvement, a low complication rate, and ease of use. The
surgical procedure appears to be safe and easy to adopt when
carried out by experienced surgeons and there does not seem to be
a signiﬁcant learning curve based on the surgical outcomes. Pa-
tients demonstrated improvement in all three major areas of
symptoms (bladder, bowel, and vagina). However, less than one
third had resumed sexual intercourse at the time of the 3e6-
month follow-up of this study. The follow-up interval in this study
may be too short to test for any sexual function improvement, as
many women will abstain from intercourse for a signiﬁcant time
after vaginal surgery. Therefore, the effect of the nonanchored
vaginal mesh procedure (Prosima) on sexual functioning needs to
be assessed using a longer follow-up period. The highest morbidity
in the current study, vaginal mesh exposure, occurred in four pa-
tients (8%) and this is a known risk with a vaginal mesh operation.
The rate is similar to previously reported rates of 8e9% for the
multicenter studies conducted by the Prosima study investigators
[11,12] and <10% rate from a recent meta-analysis [4]. However,
management seemed to be aminor issue because all of our patients
with exposed vaginal mesh were successfully treated either
conservatively or by a minor vaginal surgical procedure.
The limitations of our study are the small patient number, the
lack of a comparative group, the very short-term follow-up, and the
lack of a completely veriﬁed POP-speciﬁc instrument for theevaluation of postoperative outcomes. The absence of a comparison
group (such as a trocar-guided vaginal mesh kit group) restricts our
ability to assess the inﬂuence of nonﬁxation of the mesh on POP
repair. The strengths of this study are the homogeneous patient
population, that it is a prospective clinical trial that used stan-
dardized tools of measurement, and the implementation of a DSMP
for the short-term follow-up. Carrying out a DSMP in this study
contributed to the fact that the follow-up was conducted appro-
priately ensuring the safety and interest of our patients. At the same
time, it was especially valuable at the moment because of continual
warnings from the United States Food and Drug Administration
regarding adverse events associated with using vaginal mesh [25].
In conclusion, our ﬁndings showed that the nonanchored
vaginal mesh procedure (Prosima) is safe and produces a favorable
result in terms of anatomical support and disease-speciﬁc quality of
life at 3e6 months of follow-up. However, we also found that there
was a suboptimal suspension effect of the procedure in the pres-
ence of severe anterior vaginal wall prolapse, which may be further
affected by concomitant surgery. The information obtained con-
cerning surgical outcomes in this study will be helpful to both
physicians and patients who are planning augmented reconstruc-
tive pelvic surgery using vaginal mesh. We are continuing to follow
this cohort in order to evaluate the longer-term outcomes of the
Prosima procedure.
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